ClinConnect ClinConnect Logo
Search / Trial NCT03687528

Platelet Inhibitor Treated Patients with Head Injury Trauma Meeting NICE Criteria : is the CT-scan Mandatory ?

Launched by RENNES UNIVERSITY HOSPITAL · Sep 26, 2018

Trial Information

Current as of July 23, 2025

Recruiting

Keywords

Emergencies Platelet Inhibitors Minor Head Injury Trauma Ct Scan

ClinConnect Summary

This clinical trial is examining whether patients with head injuries who are taking antiplatelet inhibitors (medications that prevent blood clots) need to undergo a CT scan to check for brain bleeding (cerebral hemorrhage). Currently, if a patient meets certain guidelines set by NICE (a health organization), they usually get a CT scan, but there's some debate about whether this is always necessary, especially for patients with minor head injuries.

To participate in the trial, you need to be at least 18 years old, have a head injury, and have a good level of consciousness (measured by a Glasgow score of 13 to 15). You also need to be currently taking antiplatelet inhibitors. If you join the study, you’ll help researchers learn if a CT scan is truly needed for patients like you, which could change how doctors decide to use these scans in the future.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • At least 18 years old
  • Patient with a head injury trauma, described by the patient or seen at the clinical exam
  • Glasgow score between 13 and 15 at the clinical exam
  • Current treatment with antiplatelet inhibitors
  • Informed non opposition form signed
  • Exclusion Criteria :
  • Absence of CT-scanner
  • Patients with double anti-platelet aggregation
  • Patients on anticoagulants

About Rennes University Hospital

Rennes University Hospital, a leading academic medical center in France, is dedicated to advancing healthcare through innovative clinical research and trials. With a strong emphasis on patient-centered care, the hospital integrates cutting-edge scientific research with clinical practice, fostering collaboration among multidisciplinary teams. Its commitment to excellence is reflected in its robust infrastructure and expertise in various medical fields, enabling the development and evaluation of novel therapies and treatment protocols. By participating in clinical trials, Rennes University Hospital aims to enhance patient outcomes and contribute to the global body of medical knowledge.

Locations

Le Mans, , France

Nantes, , France

Poitiers, , France

Rennes, , France

Brest, , France

Angers, , France

Chartres, , France

Angers, , France

Vannes, , France

Saint Brieuc, , France

Lorient, , France

Quimperlé, , France

Saint Malo, , France

Patients applied

0 patients applied

Trial Officials

Paul-Georges REUTER, Pr

Study Director

CHU Rennes

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials